Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ACTRN12626000689370) titled 'Identification of patients not responding to immune check point inhibitor therapy using CDI-DX001 PET' on June 10.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Non-randomised trial
Primary Sponsor: Centenary Institute of Cancer Medicine and Cell Biology
Condition:
Resectable solid malignancy
Locally advanced solid malignancy
Metastatic solid malignancy
Resectable solid malignancy
Locally advanced solid malignancy
Metastatic solid malignancy
Cancer - Any cancer
Cancer - Lung - Non small cell
Cancer - Malignant melanoma
Cancer - Lung - Small cell
Cancer - Head and neck
Cancer - ...